OUE Healthcare Limited (SGX:5WA)
Singapore · Delayed Price · Currency is SGD 0.0480
0.00 (0.00%)
At close: Sep 15, 2026
OUE Healthcare Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 213 | 124 | 129 | 129 | 129 | 173 | |
Market Cap Growth | 92.00% | -3.45% | 0% | 0% | -25.64% | 21.88% |
Enterprise Value | 1,064 | 1,036 | 1,060 | 1,038 | 1,076 | 321 |
Last Close Price | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 16.01 | 29.34 | 1.56 |
PS Ratio | 1.40 | 0.82 | 0.86 | 0.81 | 1.08 | 8.81 |
PB Ratio | 0.38 | 0.19 | 0.18 | 0.17 | 0.17 | 0.54 |
P/TBV Ratio | 1.13 | 0.57 | 0.51 | 0.49 | 0.48 | 0.54 |
P/FCF Ratio | 3.57 | 2.27 | 2.14 | 1.98 | 2.53 | 55.24 |
P/OCF Ratio | 3.48 | 2.21 | 2.12 | 1.97 | 2.50 | 42.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.98 | 6.80 | 7.05 | 6.51 | 8.98 | 16.35 |
EV/EBITDA Ratio | 16.38 | 12.84 | 12.29 | 11.09 | 13.60 | 75.28 |
EV/EBIT Ratio | 17.17 | 12.94 | 12.36 | 11.15 | 13.68 | 94.88 |
EV/FCF Ratio | 17.83 | 18.90 | 17.63 | 15.96 | 21.09 | 102.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.00 | 0.85 | 0.75 | 0.74 | 0.68 | 0.58 |
Debt / EBITDA Ratio | 7.17 | 6.66 | 6.25 | 5.89 | 6.40 | 44.13 |
Debt / FCF Ratio | 9.44 | 10.09 | 9.16 | 8.62 | 10.05 | 60.07 |
Net Debt / Equity Ratio | 0.89 | 0.72 | 0.65 | 0.66 | 0.59 | 0.45 |
Net Debt / EBITDA Ratio | 6.60 | 5.80 | 5.57 | 5.35 | 5.63 | 33.80 |
Net Debt / FCF Ratio | 8.43 | 8.54 | 7.98 | 7.69 | 8.73 | 46.00 |
Asset Turnover | 0.12 | 0.11 | 0.11 | 0.11 | 0.12 | 0.03 |
Inventory Turnover | 36.19 | 38.94 | 41.62 | 46.15 | 33.99 | 19.77 |
Quick Ratio | 0.17 | 0.33 | 0.69 | 0.74 | 0.72 | 0.57 |
Current Ratio | 1.17 | 0.36 | 0.73 | 0.81 | 0.78 | 0.70 |
Return on Equity (ROE) | -1.56% | 1.23% | 3.44% | 7.60% | 6.00% | 47.68% |
Return on Assets (ROA) | 3.62% | 3.68% | 3.77% | 4.08% | 4.92% | 0.35% |
Return on Invested Capital (ROIC) | -12.78% | 2.51% | 4.39% | 5.84% | 6.15% | 0.76% |
Return on Capital Employed (ROCE) | 9.60% | 8.00% | 6.70% | 6.90% | 6.10% | 0.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -13.91% | -13.56% | -4.66% | 6.25% | 3.41% | 64.28% |
FCF Yield | 27.99% | 44.05% | 46.65% | 50.48% | 39.59% | 1.81% |
Buyback Yield / Dilution | - | - | 37.87% | - | -8.32% | -48.60% |